Publications

Please click here to see all Pubmed publications

Recent selected publications:

  1. Khamis RY, Woollard KJ, Hyde GD, Boyle JJ, Bicknell C, Chang SH, Malik TH, Hara T, Mauskapf A, Granger DW, Johnson JL, Ntziachristos V, Matthews PM, Jaffer FA, Haskard DO. Quantitative near infrared fluorescence (NIRF) molecular imaging of oxidized LDL with an autoantibody in experimental atherosclerosis. Scientific Reports| 6:21785 | DOI: 10.1038/srep21785.  PMC4766560
  2. Ughi G*, Wang H*, Gardecki JA, Gerbaud E, Fard AM, Hamidi E, Jacques-Vacas P, Rosenberg-M, Jaffer FA**, Tearney GJ**.  Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging. JACC Cardiovasc Imaging. 2016 Nov;9(11):1304-1314. doi: 10.1016/j.jcmg.2015.11.020.**Shared senior authorship; **Co-corresponding author.    PMC5010789
  3. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Patel M, Bahadorani  J, Lombardi W, Wyman RM, Grantham JA, Doing A, Moses JW, Kirtane A, Parikh M, Ali Z, Kalra S, Kandzari DE, Lembo N, Garcia S, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. International Journal of Cardiology2016 Apr 6;214:428-437. doi: 10.1016/j.ijcard.2016.03.215.
  4. Karmpaliotis D, Karatasakis A, Alaswad K, Jaffer FA, Yeh RW, Wyman RM, Lombardi WL, Grantham JA, Kandzari DE, Lembo NJ, Doing A, Patel M, Bahadorani JN, Moses JW, Kirtane AJ, Parikh M, Ali ZA, Kalra S, Nguyen-Trong PK, Danek BA, Karacsonyi J, Rangan BV, Roesle MK, Thompson CA, Banerjee S, Brilakis ES.  Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.Circulation: Cardiovascular Intervention. 2016 Jun;9(6). pii: e003434. doi: 10.1161/CIRCINTERVENTIONS.115.003434.
  5. Karacsonyi J, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, Karatasakis A, Danek BA, Doing A, Grantham JA, Karmpaliotis D, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Alame A, Nguyen-Trong PK, Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.  Journal of the American Heart Association2016;20;5(8). pii: e003890. doi: 10.1161/JAHA.116.003890.
  6. Verjans JW*, Osborn EA*, Ughi G*, Calfon Press MA, Hamidi E, Anotniadis AP, Papafaklis  MA, Conrad MF, Libby P, Stone PH, Campria RP, Tearney GJ,** Jaffer FA**.  Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.  Journal of the American College of Cardiology:Cardiovascular Imaging 2016 Sep;9(9):1087-95. doi: 10.1016/j.jcmg.2016.01.034.  **Shared senior authorship; **Co-corresponding author.  PMC5136528
  7. Ghoshhajra BB*, Takx RAP*, Stone L, Girard EE, Brilakis ES, Lombardi W, Yeh RW, Jaffer FA.Real-time Fusion of Coronary CT Angiography with X-ray Fluoroscopy During Chronic Total Occlusion PCI.  European Radiology2017;27:2464-2473 (epub 2016).
  8. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Patel MP, Mahmud E, Lombardi WL, Wyman MR, Grantham JA, Doing A, Kandzari DE, Lembo NJ, Garcia S, Toma C, Moses JW, Kirtane AJ, Parikh MA, Ali ZA, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES.  Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS CTO) Complications Score. Journal of the American Heart Association2016 Oct 11;5(10). pii: e004272.
  9. Obi AT, Andraska E, Kanthi Y, Luke CE, Elfline M, Madathilparambil S, Siahaan TJ, Jaffer FA, Wakefield TW, Raghavendran K, Henke PK.  Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis.  Journal of Vascular Research. 2016;53(3-4):186-195.
  10. Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani JN, Lombardi WL, Wyman RM, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Toma C, Moses JW, Kirtane AJ, Parikh MA, Ali ZA, Garcia S, Kalsaria P, Karacsonyi J, Alame AJ, Thompson CA, Banerjee S, Brilakis ES.  Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention. International Journal of Cardiology. 2016 Dec 1;224:50-56. doi: 10.1016/j.ijcard.2016.08.317.
  11. Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel MP, Bahadorani JN, Lombardi WL, Wyman RM, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Toma C, Moses JW, Kirtane AJ, Ali Z, Parikh M, Garcia S, Danek BA, Karacsonyi J, Alame A, Kalsaria P, Thompson C, Banerjee S, Brilakis ES. Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry. EuroIntervention. 2016 Dec 10;12(11):e1326-e1335. doi: 10.4244/EIJ-D-16-00265.
  12. Obi AT, Andraska E, Kanthi Y, Kessinger CW, Elfline M, Luke C, Siahaan TJ, Jaffer FA, Wakefield TW, Henke PK. Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia. Thromb Haemost. 2016 Dec 15. [Epub ahead of print]
  13. Bozhko D*, Osborn EA*, Rosenthal A, Verjans JWH, Hara T, McCarthy JR, Kellnberger S, Wissmeyer G, Ovsepian SV, Mauskapf A, Stein AF, Jaffer FA**,Ntziachristos V**. Quantitative Intravascular Biological Fluorescence-Ultrasound Imaging of Coronary and Peripheral Arteries In Vivo. European Heart Journal: Cardiovascular Imaging2017 (epub 2016). **Shared senior authorship; **Co-corresponding author.   PMCID – In Progress.
  14. Calfon Press MA, Mallas G, Rosenthal A, Hara T, Mauskapf A, Nudleman R, Sheehy A, Polyakov I, Kolodgie F, Virmani, R, Guerrero L, Ntziachristos V, Jaffer FA.  Everolimus-Eluting Stents Stabilize Plaque Inflammation In Vivo:  Assessment by Intravascular Fluorescence Molecular Imaging.  European Heart Journal: Cardiovascular Imaging(epub 2016).  PMCID – In Progress.
  15. Stein-Merlob AF, Hara T, McCarthy JR, Mauskapf A, Hamilton JA, Ntziachristos V, Libby P, Jaffer FA. Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging. Circulation:Cardiovascular Imaging 2017;10:e005813. DOI: 10.1161/CIRCIMAGING.116.005813. NIHMSID 868103.   PMCID – in progress
  16. Wang Y, Gao H, Kessinger CW, Schmaier A, Jaffer FA, Simon DI.  Myeloid-related protein-14 regulates deep vein thrombosis.  Journal of Clinical Investigation: Insight. 2017 Jun 2;2(11). pii: 91356. doi: 10.1172/jci.insight.91356. [Epub ahead of print]  PMC5453698
  17. Lu MT, Ferencik M, Roberts RS, Lee KL, Ivanov A, Adami E, Mark DB, Jaffer FA, Leipsic JA, Douglas PS, Hoffmann U.  Noninvasive Fractional Flow Reserve Derived From Coronary CT Angiography (FFRCT): Management and Outcomes in the PROMISE Trial.  Journal of the American College of Cardiology:Cardiovascular Imaging(epub).
  18. Secemsky EA, Gallagher R, Harkness J, Pomerantsev E, Gewritz H, *Jaffer FA, *Yeh RW. Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions. Journal of the American College of Cardiology Volume 70, Issue 9, August 2017 DOI: 10.1016/j.jacc.2017.07.713  *Shared senior authorship
  19. Tajti P, Karmpaliotis D, Alaswad K, Toma C, Choi JW, Jaffer FA, Doing AH, Patel M, Mahmud E, Uretsky B, Karatasakis A, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Prevalence, Presentation and Treatment of ‘Balloon Undilatable’ Chronic Total Occlusions: Insights from a Multicenter US Registry.Catheterization and Cardiovascular Intervention2018 Jan 23. doi: 10.1002/ccd.27510. [Epub ahead of print]
  20. Karacsonyi J, Tajti P, Rangan BV, Halligan SC, Allen RH, Nicholson WJ, Harvey JE, Spaedy AJ, Jaffer FA, Grantham JA, Salisbury A, Hart AJ, Safley DM, Lombardi WL, Hira R, Don C, McCabe JM, Burke MN, AlaswadK, Koenig GC, Sanghvi KA, Ice D, Kovach RC, Varghese V, Murad B, Baran KW, Resendes E, Martinez-Parachini JR, Karatasakis A, Danek BA, Iwnetu R, Roesle M, Khalili H, Banerjee S, Brilakis ES. Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions: The CrossBoss First Trial.  Journal of the American College of Cardiology Cardiovascular Intervention. 2018 Feb 12;11(3):225-233. doi: 10.1016/j.jcin.2017.10.023.
  21. Lino Cardenas CL, Kessinger CW, MacDonald C, Jasser AS, Isselbacher EM, Jaffer FA, Lindsay ME. Inhibition of the methyltransferase EZH2 improves aortic performance in experimental thoracic aortic aneurysm (TAA). Journal of Clinical Investigation: Insight(accepted).
  22. Lino Cardenas CL, Kessinger CW, Cheng Y, MacDonald C, McGillivray T, Ghoshhajra B, Huleihel  L, Nuri S, Yeri A, Jaffer FA, Kaminski N, Ellinor PT, Weintraub N, Malhotra R, Isselbacher EM, Lindsay ME.  An HDAC9-MALAT1-BRG1 Complex mediates smooth muscle dysfunction in thoracic aortic aneurysm.  Nature Communications (accepted).